| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| rho-Associated Kinases | 16 | 2022 | 281 | 3.500 |
Why?
|
| Clusterin | 7 | 2020 | 71 | 2.790 |
Why?
|
| Insulin Resistance | 45 | 2020 | 3964 | 2.550 |
Why?
|
| Insulin | 50 | 2020 | 6597 | 1.920 |
Why?
|
| Glucose | 31 | 2020 | 4347 | 1.580 |
Why?
|
| Leptin | 23 | 2021 | 1597 | 1.500 |
Why?
|
| Receptors, Leptin | 7 | 2021 | 350 | 1.370 |
Why?
|
| AMP-Activated Protein Kinases | 6 | 2019 | 598 | 1.360 |
Why?
|
| Agouti-Related Protein | 4 | 2020 | 93 | 1.350 |
Why?
|
| Muscle, Skeletal | 32 | 2020 | 4948 | 1.270 |
Why?
|
| Hypothalamus | 12 | 2021 | 999 | 1.050 |
Why?
|
| Energy Metabolism | 16 | 2022 | 2882 | 1.020 |
Why?
|
| Obesity | 28 | 2020 | 12947 | 0.950 |
Why?
|
| Signal Transduction | 35 | 2020 | 23447 | 0.900 |
Why?
|
| Thiazolidinediones | 4 | 2018 | 461 | 0.880 |
Why?
|
| Physical Conditioning, Animal | 6 | 2021 | 365 | 0.870 |
Why?
|
| Liver | 20 | 2020 | 7528 | 0.750 |
Why?
|
| Eating | 7 | 2020 | 1539 | 0.740 |
Why?
|
| Anti-Obesity Agents | 4 | 2018 | 227 | 0.720 |
Why?
|
| Diabetes Mellitus, Type 2 | 16 | 2020 | 12149 | 0.680 |
Why?
|
| Overnutrition | 1 | 2018 | 25 | 0.640 |
Why?
|
| PPAR gamma | 7 | 2018 | 484 | 0.630 |
Why?
|
| Proprotein Convertases | 1 | 2019 | 95 | 0.630 |
Why?
|
| Lipid Metabolism | 6 | 2021 | 1902 | 0.630 |
Why?
|
| Phosphatidylinositol 3-Kinases | 17 | 2012 | 2865 | 0.630 |
Why?
|
| Blood Glucose | 20 | 2019 | 6391 | 0.620 |
Why?
|
| Adipocytes | 10 | 2018 | 1194 | 0.600 |
Why?
|
| Isoenzymes | 9 | 2013 | 1687 | 0.590 |
Why?
|
| Resistance Training | 1 | 2020 | 193 | 0.570 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2020 | 376 | 0.550 |
Why?
|
| Lipogenesis | 1 | 2018 | 214 | 0.550 |
Why?
|
| Glucose Clamp Technique | 9 | 2020 | 263 | 0.520 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2016 | 251 | 0.500 |
Why?
|
| Homeostasis | 11 | 2022 | 3323 | 0.490 |
Why?
|
| Kidney Tubules | 1 | 2017 | 449 | 0.490 |
Why?
|
| Mice, Obese | 8 | 2018 | 420 | 0.490 |
Why?
|
| Glucose Transporter Type 4 | 8 | 2018 | 240 | 0.480 |
Why?
|
| Hypoglycemic Agents | 8 | 2020 | 3085 | 0.470 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2012 | 135 | 0.470 |
Why?
|
| Receptor, Insulin | 9 | 2020 | 836 | 0.470 |
Why?
|
| Insulin Receptor Substrate Proteins | 10 | 2012 | 557 | 0.460 |
Why?
|
| Mice, Knockout | 24 | 2022 | 14417 | 0.460 |
Why?
|
| Animals | 98 | 2022 | 168475 | 0.450 |
Why?
|
| Mice | 69 | 2022 | 81539 | 0.440 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 8 | 2008 | 96 | 0.440 |
Why?
|
| Sulfones | 1 | 2016 | 448 | 0.440 |
Why?
|
| Phosphoproteins | 9 | 2011 | 2448 | 0.430 |
Why?
|
| Phosphorylation | 25 | 2021 | 8321 | 0.420 |
Why?
|
| Cysteine Endopeptidases | 4 | 2022 | 551 | 0.410 |
Why?
|
| Peripheral Nervous System | 1 | 2013 | 151 | 0.400 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2012 | 63 | 0.400 |
Why?
|
| Neurons | 6 | 2021 | 9463 | 0.390 |
Why?
|
| Glycogen | 4 | 2013 | 251 | 0.380 |
Why?
|
| Sulfotransferases | 1 | 2012 | 150 | 0.380 |
Why?
|
| Polymerization | 1 | 2012 | 158 | 0.380 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 795 | 0.370 |
Why?
|
| Stilbenes | 1 | 2011 | 155 | 0.360 |
Why?
|
| Pro-Opiomelanocortin | 3 | 2021 | 140 | 0.360 |
Why?
|
| Postmenopause | 1 | 2020 | 2513 | 0.360 |
Why?
|
| 3T3-L1 Cells | 7 | 2018 | 209 | 0.360 |
Why?
|
| Dietary Fats | 9 | 2016 | 1995 | 0.360 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 973 | 0.340 |
Why?
|
| Physical Exertion | 2 | 2011 | 667 | 0.340 |
Why?
|
| Autophagy | 2 | 2015 | 1327 | 0.340 |
Why?
|
| Neointima | 3 | 2016 | 133 | 0.340 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 683 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 21 | 2022 | 22174 | 0.330 |
Why?
|
| Protein Kinase C | 4 | 2006 | 1202 | 0.320 |
Why?
|
| Carotid Artery Injuries | 3 | 2016 | 96 | 0.320 |
Why?
|
| Protein Tyrosine Phosphatases | 7 | 2007 | 457 | 0.320 |
Why?
|
| Fatty Acids | 5 | 2019 | 1808 | 0.310 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2018 | 517 | 0.310 |
Why?
|
| Gene Expression | 8 | 2020 | 7581 | 0.300 |
Why?
|
| Exercise | 4 | 2020 | 5890 | 0.300 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2002 | 489 | 0.290 |
Why?
|
| Glycogen Synthase Kinase 3 | 5 | 2015 | 411 | 0.290 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 2 | 2022 | 68 | 0.280 |
Why?
|
| Carrier Proteins | 5 | 2015 | 4937 | 0.280 |
Why?
|
| Obesity, Abdominal | 1 | 2010 | 374 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2002 | 4514 | 0.270 |
Why?
|
| Quinolines | 1 | 2012 | 765 | 0.260 |
Why?
|
| Monosaccharide Transport Proteins | 4 | 2002 | 436 | 0.260 |
Why?
|
| Gene Deletion | 1 | 2013 | 2665 | 0.260 |
Why?
|
| Seaweed | 2 | 2016 | 28 | 0.260 |
Why?
|
| Fatty Liver | 1 | 2012 | 790 | 0.260 |
Why?
|
| Hyperinsulinism | 5 | 2017 | 400 | 0.260 |
Why?
|
| Actins | 2 | 2012 | 2050 | 0.250 |
Why?
|
| Insulin-Secreting Cells | 4 | 2021 | 901 | 0.250 |
Why?
|
| Sirtuins | 1 | 2007 | 320 | 0.240 |
Why?
|
| Rats | 26 | 2016 | 23741 | 0.240 |
Why?
|
| Adipogenesis | 3 | 2022 | 368 | 0.230 |
Why?
|
| Adipose Tissue | 11 | 2016 | 3313 | 0.230 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 795 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2020 | 8181 | 0.230 |
Why?
|
| Male | 71 | 2022 | 360846 | 0.230 |
Why?
|
| Retinol-Binding Proteins, Plasma | 3 | 2009 | 94 | 0.230 |
Why?
|
| Motor Activity | 2 | 2013 | 2715 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 11 | 2016 | 2457 | 0.220 |
Why?
|
| STAT3 Transcription Factor | 5 | 2013 | 871 | 0.220 |
Why?
|
| Glucose Intolerance | 4 | 2019 | 575 | 0.210 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2022 | 102 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2019 | 1119 | 0.210 |
Why?
|
| Metformin | 3 | 2019 | 906 | 0.210 |
Why?
|
| Insulin Antagonists | 1 | 2002 | 17 | 0.210 |
Why?
|
| Muscles | 5 | 2007 | 1576 | 0.200 |
Why?
|
| Gluconeogenesis | 4 | 2020 | 185 | 0.200 |
Why?
|
| Peptide Fragments | 2 | 2013 | 5112 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1809 | 0.200 |
Why?
|
| Sulfonamides | 1 | 2012 | 1979 | 0.200 |
Why?
|
| Chromans | 1 | 2002 | 117 | 0.190 |
Why?
|
| Pancreas | 2 | 2021 | 1691 | 0.190 |
Why?
|
| Cells, Cultured | 13 | 2019 | 18966 | 0.190 |
Why?
|
| Lipids | 2 | 2012 | 3341 | 0.190 |
Why?
|
| Trans-Activators | 6 | 2016 | 2856 | 0.190 |
Why?
|
| Tyrosine | 6 | 2010 | 1440 | 0.190 |
Why?
|
| Energy Intake | 5 | 2018 | 2134 | 0.190 |
Why?
|
| Rats, Inbred OLETF | 7 | 2016 | 8 | 0.190 |
Why?
|
| Glycogen Synthase | 4 | 2013 | 62 | 0.190 |
Why?
|
| Gene Silencing | 1 | 2007 | 1509 | 0.180 |
Why?
|
| Adiponectin | 5 | 2012 | 1113 | 0.180 |
Why?
|
| Arabidopsis Proteins | 1 | 2002 | 264 | 0.180 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2020 | 25 | 0.180 |
Why?
|
| Body Weight | 15 | 2018 | 4618 | 0.180 |
Why?
|
| Cold-Shock Response | 1 | 2020 | 16 | 0.180 |
Why?
|
| Mice, Transgenic | 10 | 2021 | 9542 | 0.170 |
Why?
|
| Plant Proteins | 1 | 2002 | 370 | 0.170 |
Why?
|
| Potassium Channels | 1 | 2002 | 537 | 0.170 |
Why?
|
| Palmitates | 1 | 2019 | 70 | 0.160 |
Why?
|
| Adipose Tissue, White | 4 | 2022 | 365 | 0.160 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2022 | 1492 | 0.160 |
Why?
|
| Cell Line | 9 | 2020 | 15601 | 0.160 |
Why?
|
| Glucosamine | 1 | 1999 | 128 | 0.160 |
Why?
|
| Diabetes Mellitus | 7 | 2021 | 5841 | 0.160 |
Why?
|
| Diet | 4 | 2020 | 8075 | 0.160 |
Why?
|
| Minerals | 1 | 2020 | 283 | 0.150 |
Why?
|
| Gene Expression Regulation | 9 | 2018 | 11904 | 0.150 |
Why?
|
| Protective Agents | 1 | 2019 | 150 | 0.150 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2022 | 699 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2019 | 542 | 0.150 |
Why?
|
| Water Pollutants, Chemical | 1 | 2022 | 359 | 0.150 |
Why?
|
| Muscle Proteins | 3 | 2002 | 1154 | 0.150 |
Why?
|
| Down-Regulation | 3 | 2018 | 2919 | 0.140 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2010 | 276 | 0.140 |
Why?
|
| Calcium, Dietary | 1 | 2020 | 529 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 263 | 0.140 |
Why?
|
| Safflower Oil | 1 | 1996 | 29 | 0.140 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 400 | 0.140 |
Why?
|
| Carotid Artery, External | 1 | 2016 | 37 | 0.140 |
Why?
|
| Protein Phosphatase 1 | 3 | 2013 | 134 | 0.140 |
Why?
|
| Glucose Tolerance Test | 8 | 2015 | 1178 | 0.130 |
Why?
|
| Inflammation | 7 | 2020 | 10774 | 0.130 |
Why?
|
| Fats | 1 | 1996 | 99 | 0.130 |
Why?
|
| Triglycerides | 5 | 2016 | 2461 | 0.130 |
Why?
|
| Fructose | 1 | 2018 | 288 | 0.130 |
Why?
|
| Biological Transport | 5 | 2012 | 2091 | 0.130 |
Why?
|
| Mice, Mutant Strains | 4 | 2014 | 1749 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 1246 | 0.130 |
Why?
|
| Fibroblast Growth Factors | 2 | 2013 | 867 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1651 | 0.130 |
Why?
|
| Animal Feed | 3 | 2020 | 112 | 0.130 |
Why?
|
| Glucokinase | 1 | 1995 | 102 | 0.120 |
Why?
|
| Islets of Langerhans | 3 | 2007 | 1341 | 0.120 |
Why?
|
| Carboxylic Acids | 1 | 2015 | 90 | 0.120 |
Why?
|
| Enzyme Activation | 6 | 2010 | 3597 | 0.120 |
Why?
|
| Female | 31 | 2020 | 392705 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2009 | 2872 | 0.120 |
Why?
|
| Atherosclerosis | 3 | 2016 | 3407 | 0.120 |
Why?
|
| Thiazoles | 1 | 2002 | 1517 | 0.120 |
Why?
|
| Pancreatic Ducts | 1 | 2016 | 329 | 0.110 |
Why?
|
| Cholesterol | 4 | 2016 | 2905 | 0.110 |
Why?
|
| Mitochondrial Proteins | 4 | 2006 | 976 | 0.110 |
Why?
|
| Adenoviridae | 2 | 2016 | 1085 | 0.110 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2016 | 364 | 0.110 |
Why?
|
| Apolipoproteins E | 2 | 2016 | 1443 | 0.110 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 102 | 0.110 |
Why?
|
| Organ Specificity | 4 | 2013 | 1968 | 0.110 |
Why?
|
| Crosses, Genetic | 2 | 2013 | 750 | 0.110 |
Why?
|
| Dietary Carbohydrates | 3 | 1996 | 891 | 0.110 |
Why?
|
| Albuminuria | 1 | 2017 | 658 | 0.110 |
Why?
|
| Anorexia | 2 | 2013 | 154 | 0.110 |
Why?
|
| Alternative Splicing | 2 | 1995 | 1093 | 0.110 |
Why?
|
| Multienzyme Complexes | 2 | 2010 | 666 | 0.110 |
Why?
|
| Tunica Intima | 2 | 2012 | 459 | 0.100 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 1206 | 0.100 |
Why?
|
| Body Composition | 3 | 2020 | 2426 | 0.100 |
Why?
|
| Exercise Therapy | 1 | 2020 | 929 | 0.100 |
Why?
|
| Fasting | 5 | 2018 | 1603 | 0.100 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2018 | 455 | 0.100 |
Why?
|
| Trimetazidine | 1 | 2012 | 2 | 0.100 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2005 | 329 | 0.100 |
Why?
|
| Serum Amyloid P-Component | 1 | 2012 | 46 | 0.100 |
Why?
|
| Appetite Regulation | 1 | 2012 | 84 | 0.100 |
Why?
|
| Humans | 50 | 2020 | 761596 | 0.100 |
Why?
|
| Postprandial Period | 1 | 2014 | 315 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2018 | 2418 | 0.100 |
Why?
|
| Glucosides | 1 | 2016 | 512 | 0.100 |
Why?
|
| Bilirubin | 1 | 2014 | 436 | 0.100 |
Why?
|
| Macrophages | 2 | 2018 | 5767 | 0.100 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 18255 | 0.100 |
Why?
|
| Myoblasts, Skeletal | 1 | 2012 | 75 | 0.100 |
Why?
|
| Ginkgo biloba | 1 | 2011 | 27 | 0.100 |
Why?
|
| Brain | 2 | 2021 | 27121 | 0.100 |
Why?
|
| Carotid Arteries | 2 | 2015 | 941 | 0.100 |
Why?
|
| Myeloid Cells | 1 | 2016 | 823 | 0.090 |
Why?
|
| Microglia | 1 | 2020 | 1362 | 0.090 |
Why?
|
| Diarrhea | 1 | 2018 | 1318 | 0.090 |
Why?
|
| Vagus Nerve | 1 | 2014 | 458 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2016 | 5035 | 0.090 |
Why?
|
| Glycogen Phosphorylase | 2 | 2013 | 15 | 0.090 |
Why?
|
| Aminopyridines | 1 | 2015 | 573 | 0.090 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2010 | 42 | 0.090 |
Why?
|
| Biotransformation | 1 | 2010 | 166 | 0.090 |
Why?
|
| Janus Kinase 2 | 2 | 2012 | 560 | 0.090 |
Why?
|
| Behavior, Animal | 2 | 2022 | 1878 | 0.090 |
Why?
|
| Abdominal Fat | 2 | 2009 | 221 | 0.090 |
Why?
|
| Coronary Stenosis | 1 | 2016 | 794 | 0.090 |
Why?
|
| Zebrafish | 1 | 2022 | 3008 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2018 | 12130 | 0.090 |
Why?
|
| Angiopoietins | 1 | 2010 | 85 | 0.090 |
Why?
|
| Hypertriglyceridemia | 1 | 2013 | 293 | 0.090 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2009 | 46 | 0.090 |
Why?
|
| Femur | 1 | 2016 | 1307 | 0.090 |
Why?
|
| Benzhydryl Compounds | 1 | 2016 | 916 | 0.080 |
Why?
|
| Endocytosis | 1 | 2014 | 957 | 0.080 |
Why?
|
| Membrane Proteins | 4 | 2016 | 7859 | 0.080 |
Why?
|
| Mitochondria | 3 | 2021 | 3624 | 0.080 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 3430 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 234 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 4 | 2016 | 1069 | 0.080 |
Why?
|
| S-Adenosylmethionine | 1 | 2011 | 218 | 0.080 |
Why?
|
| Apoptosis | 7 | 2016 | 9490 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2020 | 2568 | 0.080 |
Why?
|
| Coronary Restenosis | 1 | 2012 | 396 | 0.080 |
Why?
|
| Lipodystrophy, Familial Partial | 1 | 2008 | 5 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2009 | 242 | 0.080 |
Why?
|
| Peritoneal Dialysis | 1 | 2010 | 159 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2015 | 2490 | 0.080 |
Why?
|
| Imidazoles | 1 | 2015 | 1180 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2011 | 1171 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2009 | 203 | 0.080 |
Why?
|
| Parasympathetic Nervous System | 1 | 2009 | 142 | 0.080 |
Why?
|
| Pericardium | 1 | 2013 | 675 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 2178 | 0.080 |
Why?
|
| Feeding Behavior | 3 | 2013 | 3188 | 0.080 |
Why?
|
| Proteins | 3 | 2001 | 6032 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 4415 | 0.080 |
Why?
|
| Particulate Matter | 1 | 2020 | 2605 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2013 | 3733 | 0.080 |
Why?
|
| Thermogenesis | 3 | 2022 | 475 | 0.080 |
Why?
|
| Middle Aged | 13 | 2020 | 220921 | 0.080 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2012 | 311 | 0.070 |
Why?
|
| Hepatitis B virus | 1 | 2011 | 528 | 0.070 |
Why?
|
| Cell Differentiation | 5 | 2018 | 11530 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2011 | 497 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1136 | 0.070 |
Why?
|
| Coenzyme A Ligases | 2 | 2019 | 45 | 0.070 |
Why?
|
| Physical Education and Training | 2 | 2011 | 102 | 0.070 |
Why?
|
| Hyperglycemia | 3 | 2011 | 1376 | 0.070 |
Why?
|
| Random Allocation | 1 | 2012 | 2395 | 0.070 |
Why?
|
| Kinetics | 2 | 2010 | 6374 | 0.070 |
Why?
|
| Lipase | 1 | 2009 | 325 | 0.070 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2019 | 82 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2013 | 1173 | 0.070 |
Why?
|
| Injections, Intraventricular | 2 | 2013 | 225 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 441 | 0.070 |
Why?
|
| Angioplasty, Balloon | 1 | 2011 | 589 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 624 | 0.070 |
Why?
|
| Calcium | 1 | 2020 | 5722 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2016 | 3396 | 0.070 |
Why?
|
| RNA, Messenger | 9 | 2010 | 12794 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2008 | 2898 | 0.070 |
Why?
|
| C-Reactive Protein | 3 | 2015 | 3826 | 0.070 |
Why?
|
| Models, Biological | 4 | 2019 | 9469 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1999 | 1058 | 0.070 |
Why?
|
| Triazoles | 1 | 2012 | 903 | 0.070 |
Why?
|
| Cell Proliferation | 7 | 2018 | 10451 | 0.070 |
Why?
|
| Cell Survival | 5 | 2019 | 5791 | 0.070 |
Why?
|
| Air Pollution | 1 | 2020 | 2359 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2011 | 865 | 0.070 |
Why?
|
| Sirtuin 1 | 1 | 2007 | 246 | 0.070 |
Why?
|
| Pyrazines | 1 | 2012 | 1202 | 0.070 |
Why?
|
| Glucose-6-Phosphate | 1 | 2005 | 29 | 0.070 |
Why?
|
| Liver Glycogen | 1 | 2005 | 35 | 0.070 |
Why?
|
| Adult | 14 | 2020 | 221210 | 0.070 |
Why?
|
| Mitochondria, Liver | 1 | 2006 | 190 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 1301 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 1 | 2009 | 471 | 0.060 |
Why?
|
| Heart | 3 | 2009 | 4404 | 0.060 |
Why?
|
| Mitochondria, Muscle | 1 | 2006 | 172 | 0.060 |
Why?
|
| Models, Animal | 1 | 2012 | 2112 | 0.060 |
Why?
|
| Diabetic Neuropathies | 1 | 2009 | 405 | 0.060 |
Why?
|
| Hexokinase | 1 | 2005 | 124 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1403 | 0.060 |
Why?
|
| Membrane Transport Proteins | 2 | 2001 | 1035 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 1342 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2015 | 4352 | 0.060 |
Why?
|
| Osmolar Concentration | 2 | 2019 | 659 | 0.060 |
Why?
|
| Transcription Factor RelA | 2 | 2016 | 254 | 0.060 |
Why?
|
| Action Potentials | 1 | 2012 | 1834 | 0.060 |
Why?
|
| Cell Communication | 2 | 2013 | 1657 | 0.060 |
Why?
|
| 3T3 Cells | 3 | 2001 | 1085 | 0.060 |
Why?
|
| Carotid Artery Diseases | 1 | 2011 | 877 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 1999 | 1991 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2005 | 175 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2009 | 944 | 0.060 |
Why?
|
| Base Sequence | 4 | 2008 | 12441 | 0.060 |
Why?
|
| Transfection | 4 | 2019 | 5774 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 3 | 2015 | 1601 | 0.060 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 16990 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2017 | 22176 | 0.060 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2003 | 43 | 0.060 |
Why?
|
| Cell Adhesion | 3 | 2016 | 3088 | 0.060 |
Why?
|
| Adenylate Kinase | 1 | 2004 | 102 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2008 | 17635 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2008 | 1080 | 0.060 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2004 | 201 | 0.050 |
Why?
|
| Risk Factors | 4 | 2020 | 74213 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3617 | 0.050 |
Why?
|
| Peptide Hormones | 1 | 2004 | 132 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5799 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2004 | 303 | 0.050 |
Why?
|
| Deoxyglucose | 2 | 2001 | 333 | 0.050 |
Why?
|
| Protein Kinase C-alpha | 1 | 2003 | 113 | 0.050 |
Why?
|
| Oxidation-Reduction | 3 | 2019 | 2231 | 0.050 |
Why?
|
| Collagen | 1 | 2011 | 2638 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2015 | 3028 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 2 | 2004 | 341 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 4758 | 0.050 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2002 | 40 | 0.050 |
Why?
|
| Immunoblotting | 3 | 2013 | 1646 | 0.050 |
Why?
|
| Abdomen | 1 | 2008 | 1128 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 1486 | 0.050 |
Why?
|
| Proinsulin | 2 | 2009 | 135 | 0.050 |
Why?
|
| Time Factors | 8 | 2020 | 39969 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2009 | 1014 | 0.050 |
Why?
|
| Aged | 8 | 2020 | 169310 | 0.050 |
Why?
|
| Cricetinae | 1 | 2005 | 2423 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2013 | 3096 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2009 | 2264 | 0.050 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2022 | 108 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5672 | 0.050 |
Why?
|
| Chemokine CCL2 | 2 | 2015 | 605 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 2008 | 1189 | 0.050 |
Why?
|
| Glycerol | 1 | 2002 | 274 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3201 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2004 | 1699 | 0.050 |
Why?
|
| Body Mass Index | 3 | 2012 | 12953 | 0.050 |
Why?
|
| beta Catenin | 1 | 2006 | 1040 | 0.050 |
Why?
|
| Myocardium | 4 | 2009 | 4725 | 0.040 |
Why?
|
| Transgenes | 1 | 2004 | 1010 | 0.040 |
Why?
|
| Phytic Acid | 1 | 2020 | 22 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2000 | 131 | 0.040 |
Why?
|
| Disease Progression | 1 | 2017 | 13510 | 0.040 |
Why?
|
| Hormones | 1 | 2004 | 869 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 1741 | 0.040 |
Why?
|
| Hyperphagia | 1 | 2020 | 139 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4431 | 0.040 |
Why?
|
| Organ Size | 2 | 2009 | 2254 | 0.040 |
Why?
|
| src Homology Domains | 1 | 2000 | 361 | 0.040 |
Why?
|
| Adipocytes, Brown | 1 | 2020 | 150 | 0.040 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2004 | 435 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 974 | 0.040 |
Why?
|
| I-kappa B Kinase | 1 | 2020 | 250 | 0.040 |
Why?
|
| Adiposity | 1 | 2009 | 1879 | 0.040 |
Why?
|
| Phosphorus | 1 | 2020 | 335 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2007 | 1387 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 1616 | 0.040 |
Why?
|
| Exons | 2 | 1995 | 2391 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10766 | 0.040 |
Why?
|
| Bone Density | 1 | 2012 | 3551 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1175 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2004 | 1328 | 0.040 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2018 | 56 | 0.040 |
Why?
|
| Diabetes, Gestational | 1 | 2008 | 1248 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4576 | 0.040 |
Why?
|
| Glycolysis | 1 | 2002 | 835 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 21019 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2007 | 3208 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2022 | 665 | 0.040 |
Why?
|
| Zinc | 1 | 2022 | 690 | 0.040 |
Why?
|
| Ecosystem | 1 | 2022 | 490 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2010 | 2472 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2001 | 393 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2002 | 1139 | 0.030 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 11076 | 0.030 |
Why?
|
| DNA Damage | 1 | 2006 | 2449 | 0.030 |
Why?
|
| Protein Binding | 3 | 2014 | 9353 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 579 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 286 | 0.030 |
Why?
|
| Prealbumin | 2 | 2008 | 222 | 0.030 |
Why?
|
| Phosphates | 1 | 2020 | 770 | 0.030 |
Why?
|
| Venoms | 1 | 2016 | 94 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 2917 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 296 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 764 | 0.030 |
Why?
|
| Phenotype | 3 | 2022 | 16592 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 1995 | 11 | 0.030 |
Why?
|
| Incretins | 1 | 2016 | 99 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2018 | 553 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 318 | 0.030 |
Why?
|
| Glucose Transporter Type 2 | 1 | 1995 | 61 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 6075 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 9610 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 283 | 0.030 |
Why?
|
| Amides | 1 | 2018 | 449 | 0.030 |
Why?
|
| PPAR delta | 1 | 2015 | 40 | 0.030 |
Why?
|
| Kidney | 1 | 2010 | 7048 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3113 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 789 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 3415 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 2015 | 149 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 459 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1612 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2016 | 250 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2016 | 296 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2016 | 590 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1995 | 473 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2014 | 242 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1995 | 477 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 615 | 0.030 |
Why?
|
| Sympathetic Nervous System | 2 | 2009 | 518 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2022 | 1927 | 0.030 |
Why?
|
| Reference Values | 1 | 2000 | 4920 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2005 | 2781 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 517 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2013 | 1406 | 0.030 |
Why?
|
| Choroid | 1 | 2015 | 360 | 0.030 |
Why?
|
| Starvation | 1 | 2013 | 142 | 0.030 |
Why?
|
| Proteomics | 2 | 2016 | 3848 | 0.020 |
Why?
|
| Cell Movement | 2 | 2016 | 5205 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 1027 | 0.020 |
Why?
|
| Ion Channels | 3 | 2001 | 1040 | 0.020 |
Why?
|
| Weight Loss | 1 | 2003 | 2684 | 0.020 |
Why?
|
| Ginkgolides | 1 | 2011 | 7 | 0.020 |
Why?
|
| Phosphotyrosine | 2 | 2004 | 456 | 0.020 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2011 | 21 | 0.020 |
Why?
|
| Kaempferols | 1 | 2011 | 21 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2015 | 636 | 0.020 |
Why?
|
| Phagosomes | 1 | 2013 | 199 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 73 | 0.020 |
Why?
|
| Glutathione | 1 | 2014 | 583 | 0.020 |
Why?
|
| Choroidal Neovascularization | 1 | 2015 | 363 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2014 | 366 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2139 | 0.020 |
Why?
|
| Cyclopentanes | 1 | 2011 | 87 | 0.020 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2011 | 153 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 383 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 277 | 0.020 |
Why?
|
| U937 Cells | 1 | 2011 | 261 | 0.020 |
Why?
|
| Epididymis | 1 | 2013 | 228 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6228 | 0.020 |
Why?
|
| Quercetin | 1 | 2011 | 97 | 0.020 |
Why?
|
| DNA Primers | 1 | 1995 | 2820 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2021 | 0.020 |
Why?
|
| Cattle | 1 | 1996 | 3849 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 379 | 0.020 |
Why?
|
| Furans | 1 | 2011 | 202 | 0.020 |
Why?
|
| Sympathomimetics | 1 | 2009 | 56 | 0.020 |
Why?
|
| Korea | 1 | 2009 | 98 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 3713 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2010 | 130 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2009 | 1252 | 0.020 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2009 | 61 | 0.020 |
Why?
|
| COS Cells | 2 | 2002 | 1130 | 0.020 |
Why?
|
| Receptors, Neuropeptide | 1 | 2009 | 106 | 0.020 |
Why?
|
| Cholinergic Agents | 1 | 2009 | 96 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 731 | 0.020 |
Why?
|
| Carbachol | 1 | 2009 | 223 | 0.020 |
Why?
|
| Albumins | 1 | 2011 | 575 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 309 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3810 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 578 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3578 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 1134 | 0.020 |
Why?
|
| Gene Targeting | 2 | 2001 | 838 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 484 | 0.020 |
Why?
|
| Aorta | 1 | 2015 | 2041 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 7593 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2012 | 973 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 3597 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2015 | 1007 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 2417 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2009 | 982 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 927 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2010 | 888 | 0.020 |
Why?
|
| Vasculitis | 1 | 2011 | 521 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 3517 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6214 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2015 | 2910 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 4001 | 0.020 |
Why?
|
| Pyridines | 1 | 2018 | 2875 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2242 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 293 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 1791 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9420 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 5790 | 0.020 |
Why?
|
| Cytokines | 2 | 2015 | 7396 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 1007 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 15502 | 0.020 |
Why?
|
| Lac Operon | 1 | 2005 | 237 | 0.020 |
Why?
|
| Receptors, Ghrelin | 1 | 2004 | 20 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2008 | 791 | 0.010 |
Why?
|
| Receptors, Melanocortin | 1 | 2004 | 23 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1996 | 2576 | 0.010 |
Why?
|
| Peptides | 1 | 2016 | 4358 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2008 | 1638 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2006 | 712 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2011 | 1233 | 0.010 |
Why?
|
| Milk Proteins | 1 | 2004 | 163 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 2004 | 265 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2012 | 4021 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 1532 | 0.010 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2006 | 855 | 0.010 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2010 | 1039 | 0.010 |
Why?
|
| Cell Division | 1 | 2011 | 4465 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 813 | 0.010 |
Why?
|
| Heart Atria | 1 | 2009 | 1345 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2645 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 2805 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 878 | 0.010 |
Why?
|
| Ghrelin | 1 | 2004 | 252 | 0.010 |
Why?
|
| Phentolamine | 1 | 2002 | 102 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2011 | 2136 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2008 | 1866 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 2206 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 30053 | 0.010 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2002 | 72 | 0.010 |
Why?
|
| Age Factors | 2 | 2009 | 18399 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 2001 | 46 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2009 | 1608 | 0.010 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2001 | 10 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2002 | 395 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2002 | 174 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2001 | 120 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2006 | 1201 | 0.010 |
Why?
|
| Genistein | 1 | 2001 | 86 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11120 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2065 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4243 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 14665 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 345 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 1668 | 0.010 |
Why?
|
| Exercise Test | 1 | 2008 | 2127 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 328 | 0.010 |
Why?
|
| Lactates | 1 | 2001 | 405 | 0.010 |
Why?
|
| Motivation | 1 | 2009 | 2006 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2002 | 705 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2004 | 2217 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2001 | 685 | 0.010 |
Why?
|
| Androstadienes | 1 | 2001 | 348 | 0.010 |
Why?
|
| Doxycycline | 1 | 2001 | 344 | 0.010 |
Why?
|
| Risk | 1 | 2011 | 9610 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1848 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2006 | 2209 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3769 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 5368 | 0.010 |
Why?
|
| Linear Models | 1 | 2008 | 5872 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2006 | 1250 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 4125 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20100 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2009 | 3807 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2006 | 4142 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 6056 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2001 | 1561 | 0.010 |
Why?
|
| Aging | 1 | 2015 | 8710 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 1989 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 6403 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 14608 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 2425 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 15733 | 0.010 |
Why?
|
| Weight Gain | 1 | 2002 | 2348 | 0.010 |
Why?
|
| Adolescent | 2 | 2011 | 88326 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2001 | 3687 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 6534 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 12990 | 0.010 |
Why?
|
| Hippocampus | 1 | 2002 | 3766 | 0.010 |
Why?
|
| Pregnancy | 1 | 2008 | 29890 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 20568 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 59260 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 58984 | 0.000 |
Why?
|
| Child | 1 | 2012 | 80158 | 0.000 |
Why?
|
| Neoplasms | 1 | 2011 | 22173 | 0.000 |
Why?
|